Hot International Companies To Own For 2016

Hot International Companies To Own For 2016: Evoke Pharma Inc (EVOK)

Evoke Pharma, Inc., incorporated on January 29, 2007, is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The Companys lead product candidate, EVK-001, is in late stage clinical testing. EVK-001 is a formulation of this drug, designed to provide systemic delivery of metoclopramide through intranasal administration.

Gastroparesis is a condition of delayed gastric emptying in the absence of mechanical obstruction. Gastroparesis results in food remaining in the stomach for a longer time than normal, yielding a variety of symptoms. Gastroparesis is a common problem in individuals with diabetes, but also is observed in patients with prior gastric surgery, a preceding infectious i llness, pseudo-obstruction, collagen vascular disorders and anorexia nervosa. EVK-001 is designed to effectively bypass the digestive system and allow for more predictable drug administration of its nasal spray formulation across the thin mucosa in the nasal cavity.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  The first, Evoke Pharma Inc. (Nasdaq: EVOK), will release data from a phase 3 trial of its experimental drug EVK-001, a potential treatment for women with recurrent diabetic gastroparesis. The data follows successful results from a previous phase 2 study of the drug.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-international-companies-to-own-for-2016.html